Historic Approval for MASH, CAR-Ts in the Spotlight 3/20/2024

What Another Trump Presidency Could Mean for Big Pharma 3/20/2024

Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label 3/20/2024

How to Talk About Politics at Work 3/20/2024

Novo Invests $556M in China Operations to Boost Manufacturing Capacity 3/20/2024

Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA 3/20/2024

EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies 3/20/2024

Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC 3/20/2024

With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs? 3/20/2024

AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree 3/19/2024

Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study 3/19/2024

Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward 3/19/2024

Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission 3/19/2024

Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease 3/19/2024

Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch 3/19/2024

Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis 3/19/2024

Report: 2024 U.S. Life Sciences Salary Trends 3/19/2024

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need 3/18/2024

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data 3/18/2024

J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline 3/18/2024